STRM.BIO

STRM.BIO is a preclinical, VC-backed biotechnology company leveraging extracellular vesicles (EVs) to deliver gene therapies in a better way: simpler, safer, and more practical. Our work will open the door to a medical future for rare disease patients worldwide. STRM.BIO is committed to bringing gene therapies to life.